76
Participants
Start Date
December 20, 2007
Primary Completion Date
June 14, 2010
Study Completion Date
June 14, 2010
ILV-094
SC and IV administration on days 1, 14, 28, and 42
Parexel George, George
FARMOVS Parexel (Pty) Ltd, Bloemfontein
New York University Medical Center, New York
Mount Sinai School of Medicine, New York
Duke Clinical Reseach Unit, Durham
Miami Research Associates, South Miami
MRA Clinical Research, South Miami
The Cleveland Clinic Foundation, Cleveland
Dawes Fretzin Clinical Research Group, Indianapolis
Dawes Fretzin Dermatology Group, Indianapolis
Hudson Dermatology, Evansville
Hamzavi Dermatology, Fort Gratiot
Central Dermatology, St Louis
David Stoll, MD, Beverly Hills
Dermatology Research, Santa Monica
Altoona Center for Clinical Research, Duncansville
Baylor Research Institute, Dallas
Stratical Medical, Edmonton
University of Alberta, Hospital Site Clinical Sciences Building, Edmonton
The Northern Alberta Clinical Trials and Research Centre (NACTRC), Edmonton
Bio Pharma Services Inc, Toronto
K. Papp Clinical Research, Waterloo
Innovaderm Recherches Inc, Montreal
Queen Mary Hospital, Hong Kong
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY